Prostate Cancer

COMPARATIVE EFFECTIVENESS OF LOCAL AND SYSTEMIC THERAPY FOR T4 PROSTATE CANCER. July 16, 2018

National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms. July 16, 2018

FDA Approves enzalutamide for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC) July 14, 2018

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. July 13, 2018

Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy. July 13, 2018

A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS. July 13, 2018

Molecular underpinnings of enzalutamide resistance. July 13, 2018

Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study. July 13, 2018

Relevance of poly (ADP-ribose) polymerase inhibitors in prostate cancer. July 12, 2018

Ga-68-PSMA PET/CT in treatment-naïve patients with prostate cancer: Which clinical parameters and risk stratification systems best predict PSMA-positive metastases? July 12, 2018

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial. July 12, 2018

Cost analysis of prostate cancer detection including the prostate health index (phi). July 12, 2018

Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study. July 12, 2018

The Scatter Search Based Algorithm for Beam Angle Optimization in Intensity-Modulated Radiation Therapy. July 12, 2018

Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer. July 12, 2018

miR Scientific Appoints Laurence Klotz, M.D., FRCSC, as Chief Medical Officer July 11, 2018

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. July 11, 2018

Metastatic prostate cancer mimicking a subdural hematoma: A case report and literature review. July 11, 2018

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. July 11, 2018

Can Early Dynamic Positron Emission Tomography/Computed Tomography Obviate the Need for Postdiuresis Image in 68Ga-PSMA-HBED-CC Scan for Evaluation of Prostate Adenocarcinoma? July 11, 2018

Page 1 of 827